Cel-Sci
CVM
#9766
Rank
โ‚ฌ44.28 M
Marketcap
5,54ย โ‚ฌ
Share price
2.54%
Change (1 day)
-65.09%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚ฌ11.43 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are โ‚ฌ11.43 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30โ‚ฌ12.68 M-22.45%
2023-09-30โ‚ฌ16.35 M-12.85%
2022-09-30โ‚ฌ18.76 M12.33%
2021-09-30โ‚ฌ16.7 M-5.87%
2020-09-30โ‚ฌ17.74 M-13.99%
2019-09-30โ‚ฌ20.63 M-19.06%
2018-09-30โ‚ฌ25.49 M13.98%
2017-09-30โ‚ฌ22.36 M-1.94%
2016-09-30โ‚ฌ22.8 M-23.51%
2015-09-30โ‚ฌ29.82 M328.57%
2014-09-30โ‚ฌ6.95 M127.4%
2013-09-30โ‚ฌ3.05 M-56.64%
2012-09-30โ‚ฌ7.05 M0.33%
2011-09-30โ‚ฌ7.03 M-3.7%
2010-09-30โ‚ฌ7.3 M-71.49%
2009-09-30โ‚ฌ25.61 M833.22%
2008-09-30โ‚ฌ2.74 M-35.52%
2007-09-30โ‚ฌ4.25 M-49.07%
2006-09-30โ‚ฌ8.35 M917.54%
2005-09-30โ‚ฌ0.82 M-26.7%
2004-09-30โ‚ฌ1.12 M-22.89%
2003-09-30โ‚ฌ1.45 M-47.34%
2002-09-30โ‚ฌ2.76 M394.78%
2001-09-30โ‚ฌ0.55 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Curis
CRIS
โ‚ฌ36.35 M 218.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.71 B 6,167.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ69.16 B 604,814.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.20 B 1,729.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.00 B 244,819.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 852,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.75 B 6,499.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ2.23 M-80.45%๐Ÿ‡บ๐Ÿ‡ธ USA